The Antidepressant Effects of rTMS After Ischemic Stroke

Status Recruiting

Clinical Trial Summary

This is a multicenter, randomized, double-blind, placebo-controlled trial aims to assess the effectiveness of repetitive transcranial magnetic stimulation(rTMS) in treating depression after basal ganglia ischemic stroke and to examine whether such effects are related to restoration of white matter integrity.Sixty-six participants will be recruited from three centers and randomized with a 1:1 ratio to receive active rTMS treatment or sham rTMS treatment in addition to routine supportive treatments.The data of neuropsychological tests and MRI will be collected at 0, 2 and 4 weeks after the commencement of the treatment.

Clinical Trial Description

This is a multicenter, randomized, double-blind, placebo-controlled trial aims to assess the effectiveness of rTMS in treating depression after basal ganglia ischemic stroke and to examine whether such effects are related to restoration of white matter integrity.Sixty-six participants will be recruited from three centers and randomized with a 1:1 ratio to receive active rTMS treatment or sham rTMS treatment in addition to routine supportive treatments.The data of neuropsychological tests and MRI will be collected at 0, 2 and 4 weeks after the commencement of the treatment.The primary outcome is the measurement of 24-item Hamilton Depression Rating Scale (HAMD-24) scores, and the secondary outcomes include diffusion tensor imaging (DTI) results and the results of neuropsychological tests including National Institutes of Health Stroke Scale (NIHSS), Activities of Daily Living Scale (ADLs), Montreal Cognitive Assessment (MoCA),Clinical Global Impressions scales(CGI), Aphasia Battery in Chinese (ABC), Social Support Revalued Scale (SSRS) and Medical Coping Questionnaire (MCMQ). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03159351
Study type	Interventional
Source	Zhujiang Hospital
Contact	Lianxu Zhao, M.D
Phone	020-62783082
Email	zhaolianxu@smu.edu.cn
Status	Recruiting
Phase	N/A
Start date	November 20, 2017
Completion date	May 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05612659` - Developing an EEG Probe for Studying and Modulating Cognitive Control	N/A
Active, not recruiting	`NCT06451965` - SCED - Wisdom Enhancement for Post-Stroke Depression	N/A
Completed	`NCT04093843` - TMS for Post Stroke Depression	N/A
Recruiting	`NCT05516680` - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD	N/A
Recruiting	`NCT04876066` - Use of Transmucosal Ketamine in Post Stroke Depression	Phase 1
Recruiting	`NCT03864484` - iPad Application-based Intervention for Post-stroke Depression	N/A
Recruiting	`NCT05310175` - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression	N/A
Completed	`NCT03639259` - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed	`NCT02472613` - Acupuncture for Ischemic Post-stroke Depression	N/A
Completed	`NCT04008719` - ATtention Test and Executive Functions After STroke to Predict Depression.	N/A
Recruiting	`NCT05241782` - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients	N/A
Withdrawn	`NCT03761303` - rTMS as an add-on Therapy in Patients With Post-stroke Depression	N/A
Completed	`NCT04318951` - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia	N/A
Completed	`NCT04560413` - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting	`NCT05187975` - Integrated Rehabilitation in Treating Post-stroke Depression	N/A
Completed	`NCT06157333` - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression	N/A
Completed	`NCT03829397` - To Investigate the Correlation of Stroke Patients and Demoralized
Recruiting	`NCT03256305` - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression	N/A
Recruiting	`NCT03789994` - Affective Touching on Poststroke Depression	N/A
Completed	`NCT05932550` - Safety of Maraviroc for Post-stroke Depression	Phase 2